Neogen (NEOG) Projected to Announce Quarterly Earnings on Tuesday

Neogen (NASDAQ:NEOG) is projected to post its Q1 2027 results before the market opens on Tuesday, October 6th. Analysts expect the company to announce earnings of $0.0533 per share and revenue of $208.1750 million for the quarter. Individuals may visit the the company’s upcoming Q1 2027 earning report page for the latest details on the call scheduled for Tuesday, October 6, 2026 at 4:30 PM ET.

Neogen (NASDAQ:NEOG) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.03. Neogen had a negative net margin of 0.91% and a positive return on equity of 2.78%. The business had revenue of $225.30 million during the quarter, compared to analyst estimates of $212.35 million. During the same quarter in the previous year, the business posted ($2.82) earnings per share. The company’s revenue was down .1% on a year-over-year basis. On average, analysts expect Neogen to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Neogen Stock Down 0.7%

Shares of NASDAQ NEOG opened at $12.15 on Friday. The firm has a market cap of $2.65 billion, a P/E ratio of -405.00, a price-to-earnings-growth ratio of 4.56 and a beta of 1.79. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.91 and a current ratio of 3.82. Neogen has a 1 year low of $5.37 and a 1 year high of $14.26. The firm’s 50 day moving average price is $11.95 and its 200 day moving average price is $10.19.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on NEOG. Wall Street Zen upgraded Neogen from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Weiss Ratings raised Neogen from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Piper Sandler raised Neogen from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $13.00 to $14.00 in a report on Wednesday, August 26th. Finally, Guggenheim reaffirmed a “buy” rating and set a $14.00 target price (up from $12.00) on shares of Neogen in a report on Wednesday. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $12.67.

Neogen Company Profile

Neogen Corporation is a global provider of food safety and animal safety products and services. The company develops diagnostic tests, laboratory products, and related solutions that help customers detect foodborne pathogens, allergens, toxins, residues, and other contaminants throughout the food production process.

Its food safety portfolio includes test kits, culture media, molecular testing systems, sanitation monitoring products, and laboratory supplies used by food manufacturers, processors, retailers, and regulatory organizations.